Crossmark

Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to<i>Francisella tularensis</i>

Crossref DOI link: https://doi.org/10.1073/pnas.1900144116

Published Online: 2019-03-14

Published Print: 2019-04-02

Update policy: https://doi.org/10.1073/pnas.cm10313

Authors

Stefanetti, Giuseppe

Okan, Nihal

Fink, Avner

Gardner, Erica

Kasper, Dennis L. https://orcid.org/0000-0001-8808-5333
Funding

Funding for this research was provided by:

NIAID, NIH (5R01AI089915)

NIAID, NIH (5U19AI109764)

European Union's Horizon 2020 Research and Innovation Programme under Marie Skłodowska Curie Grant Agreement (661138)
License Information

Version of Record valid from 2019-03-14
More Information

Publication History

Published: 2019-03-14